<DOC>
	<DOCNO>NCT01334554</DOCNO>
	<brief_summary>Obesity great detrimental impact health African American woman racial gender group . Nearly 80 % African American woman overweight obese United States . Hypertension insulin resistance prevalent among African American woman compare men Caucasians . These condition put increase risk development diabetes mellitus cardiovascular disease . Recent study report substance name Nitric Oxide ( NO ) may beneficial effect body handle blood sugar blood pressure . Of interest , study show African Americans decrease function NO blood vessel . In study proposal investigator test increase NO function PDE-5 inhibitor ( sildenafil citrate ) improve pre-diabetes health inner layer blood vessel obese African American woman .</brief_summary>
	<brief_title>Study Sildenafil Citrate Insulin Resistance African American</brief_title>
	<detailed_description />
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Race selfdefined , subject report parent race include . Age 1860 year old . The investigator recruit subject wide range BMI 3045 kg/m2 . Subjects metabolic syndrome fast insulin &gt; 13 . The diagnosis include 3 follow : Fasting blood glucose great 100 Triglyceride level great 150 HDL cholesterol le 50 woman Blood pressure least 130/85 , blood pressure medicine Waist girth 35 inch woman . Subjects childbearing potential require negative serum/urine pregnancy test . In addition , ask use reliable contraceptive method prior enrollment determine PI ( Dr. Cyndya Shibao ) . Previous allergic reaction study medication ( sildenafil ) inability take study medication prescribe course study . Type 1 2 diabetes mellitus define fast glucose 126 mg/dl great . Use antidiabetic medication ( insulin , metformin , sulfonylurea , troglitazone ) Cardiovascular disease myocardial infarction within 6 month prior enrollment , presence angina pectoris , significant arrhythmia , congestive heart failure ( LV hypertrophy acceptable ) , deep vein thrombosis , pulmonary embolism , second third degree heart block , mitral valve stenosis , aortic stenosis hypertrophic cardiomyopathy . Current smoker . Significant weight change &gt; 5 % baseline past three month . Pregnancy breastfeed . History serious neurological disease cerebral hemorrhage stroke , transient ischemic attack . History presence immunological hematological disorder . Clinical significant gastrointestinal impairment could interfere drug absorption . Impaired hepatic function ( aspartate amino transaminase [ AST ] and/or alanine amino transaminase [ ALT ] &gt; 1.5X upper limit normal range ) . Impaired renal function ( estimate glomerular filtration rate ( eGFR ) &lt; 60mL/min ) . Any underlying acute disease require regular medication could possibly pose threat subject make implementation protocol interpretation study result difficult . History alcohol drug abuse . Mental condition render subject unable understand nature , scope possible consequence study . Inability comply protocol , e.g . uncooperative attitude , inability return followup visit , unlikelihood completing study . Patients must take nitratest form ( e.g. , nitroglycerin , isosorbide dinitrate , nitroprusside , others ) study Patients alphablocking drug ( doxazosin , terazosin , prazosin ) exclude Patients protease inhibitor ( ritonavir others ) exclude</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>African American</keyword>
	<keyword>Women</keyword>
	<keyword>Metabolic Syndrome</keyword>
	<keyword>Endothelial function</keyword>
	<keyword>Sildenafil citrate</keyword>
</DOC>